{"id":123155,"date":"2017-06-20T11:00:04","date_gmt":"2017-06-20T11:00:04","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=123155"},"modified":"2017-06-20T11:00:04","modified_gmt":"2017-06-20T11:00:04","slug":"global-nerve-repair-biomaterials-market-industry-analysis-and-forecast-to-2024","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-nerve-repair-biomaterials-market-industry-analysis-and-forecast-to-2024_123155.html","title":{"rendered":"Global Nerve Repair Biomaterials Market &#8211; Industry Analysis and Forecast to 2024"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2017\/06\/1479473416.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2017\/06\/1479473416.png\" alt=\"\" width=\"225\" height=\"65\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;The actual calculation year for the report in 2016, while the historic data is for 2015 and the forecast period is still 2024&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Global Nerve Repair Biomaterials Market, By Product Type (Nerve Repair (Nerve Conduit, Nerve Graft (Allograft, Acellularized Allograft)), Nerve Protection (Nerve Protectors, Nerve Wrap), By Injury Type (Epineural Nerve Repair, Perineural Nerve Repair, Group Fascicular Repair), By End User (Hospital, Clinics, Ambulatory Trauma Centers), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) \u2013 Trends and Forecast to 2024<\/div>\n<p style=\"text-align: justify;\">The market is expected to reach USD 775.59 million by 2024 from USD 326.71 million in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024.<\/p>\n<p style=\"text-align: justify;\"><strong>Ask for Sample:<\/strong> <a rel=\"nofollow\" href=\"http:\/\/databridgemarketresearch.com\/request-a-sample\/?chalet=Global%20Nerve%20Repair%20Biomaterials%20Market%20-%20Industry%20Trends%20and%20Forecast%20to%202024\">Global Nerve Repair Biomaterials Market &ndash; Industry Trends and Forecast to 2024<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Key Drivers:<\/strong><\/p>\n<p style=\"text-align: justify;\">The global nerve repair biomaterials market is witnessing a rapid growth due to increasing geriatric population, rising number of nerve injuries and nerve surgeries,high incidence of neurological disorders, favorable reimbursement policies, and increased government funding.<\/p>\n<ul style=\"text-align: justify;\">\n<li>The geriatric population is increasing rapidly in most of the regions due to which the incidence of peripheral nerve injuries is also increasing such as Alzheimer&rsquo;s epilepsy and Parkinson&rsquo;s disease.<\/li>\n<li>The development of allograft products can bridge nerve gaps over the size of 3cm which was not a possibility using autografts.<\/li>\n<li>Surgical advancements regarding spinal cord injury and emerging market may enhance the growth of the market in the future.<\/li>\n<li>Technological advancements is expected to be the major driver for this market.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Segmentation:<\/strong><\/p>\n<p style=\"text-align: justify;\">The market is segmented based on product type, injury type, end- user, geography, and major players.<\/p>\n<p style=\"text-align: justify;\">The global nerve repair biomaterials market is segmented by type into:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Nerve Repair\n<ul>\n<li>Nerve Conduit,<\/li>\n<li>Nerve Graft\n<ul>\n<li>Allograft<\/li>\n<li>Acellularized Allograft<\/li>\n<li>Nerve Protection\n<ul>\n<li>Nerve Protectors<\/li>\n<li>Nerve Wrap<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">The global nerve repair biomaterials market is segmented by injury type into:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Body Composition Analysis<\/li>\n<li>Fracture Diagnosis<\/li>\n<li>Bone Densitometry<\/li>\n<li>Fracture Risk Assessment<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">The global nerve repair biomaterials market is segmented by end-user into:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Hospital<\/li>\n<li>Clinics<\/li>\n<li>Ambulatory Trauma Centers<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.<\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"http:\/\/databridgemarketresearch.com\/reports\/global-nerve-repair-biomaterials-market-trends-forecast-2024\/\" target=\"_blank\"><img decoding=\"async\" style=\"display: block; margin-left: auto; margin-right: auto;\" src=\"http:\/\/www.abnewswire.com\/uploads\/75f2bf362e00fc26af147b6cde2240b8.jpg\" alt=\"\" \/><\/a><\/p>\n<p style=\"text-align: justify;\"><strong>To read more about the scope of the report:<\/strong> <a rel=\"nofollow\" href=\"http:\/\/databridgemarketresearch.com\/global-nerve-repair-biomaterials-market-growing-significant-rate-forecast-period-2017-2024\/\">Global Nerve Repair Biomaterials Market Is Growing At A Significant Rate In The Forecast Period 2017-2024<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Major Players Covered In this Report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Integra LifeSciences Corporation<\/li>\n<li>Stryker<\/li>\n<li>Collagen Matrix, Inc.<\/li>\n<li>AxoGen, Inc.<\/li>\n<li>Checkpoint Surgical, Inc.<\/li>\n<li>Polyganics<\/li>\n<li>Synovis Micro Companies Alliance, Inc.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Request for buying: <\/strong><a rel=\"nofollow\" href=\"http:\/\/databridgemarketresearch.com\/reports\/global-nerve-repair-biomaterials-market-trends-forecast-2024\/\">Global Nerve Repair Biomaterials Market &ndash; Industry Trends and Forecast to 2024<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents:<\/strong><\/p>\n<p style=\"text-align: justify;\">1. INTRODUCTION<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 1.1. OVERVIEW OF THE NERVE REPAIR BIOMATERIALS MARKET<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 1.2. MARKET SEGMENTATION &amp; COVERAGE<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 1.2.1. CURRENCY AND PRICING<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 1.2.2. LIMITATION<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 1.2.3. STAKEHOLDERS<\/p>\n<p style=\"text-align: justify;\">2. RESEARCH METHODOLOGY<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 2.1. KEY TAKEAWAYS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 2.2. ARRIVING AT THE GLOBAL NERVE REPAIR BIOMATERIALS MARKET SIZE<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2.2.1. MARKET CRACKDOWN APPROACH<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2.2.3. DATA TRIANGULATION<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2.2.6. PORTER&rsquo;S FIVE FORCES MATRIX<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 2.3. GLOBAL NERVE REPAIR BIOMATERIALS MARKET: RESEARCH SNAPSHOT<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 2.4. ASSUMPTIONS<\/p>\n<p style=\"text-align: justify;\">3. MARKET LANDSCAPE SUMMARY<\/p>\n<p style=\"text-align: justify;\">4. PREMIUM INSIGHTS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 4.1. OVERVIEW<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 4.2. GLOBAL NERVE REPAIR BIOMATERIALS MARKET: KEY PRIMARY INSIGHTS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 4.3. MARKET OVERVIEW<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4.3.1. DRIVERS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;4.3.1.1. INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;4.3.1.2. TECHNOLOGICAL DEVELOPMENT IN NERVE REPAIR<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;4.3.1.3. FAVORABLE REIMBURSEMENT POLICIES<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;4.3.1.4. EXPANDED TARGET APPLICATIONS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4.3.2. RESTRAINTS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;4.3.2.1. LACK OF PATIENT AWARENESS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;4.3.2.2. LACK OF PROFESSIONALS, INCLUDING TRAINED SURGEONS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4.3.3. OPPURTUNITIES<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;4.3.3.1. NOVEL THERAPIES SUCH AS STEM CELL THERAPY<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;4.3.3.2. RISING ACCEPTANCE OF EMERGING MARKETS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4.3.4. THREATS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;4.3.4.1. DONOR SITE MORBIDITY<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;4.3.4.2. INADEQUATE NERVE REGENERATION BY CONDUITS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES<\/p>\n<p style=\"text-align: justify;\">5. EXECUTIVE SUMMARY<\/p>\n<p style=\"text-align: justify;\">6. NERVE REPAIR BIOMATERIALS MARKET, BY PRODUCT TYPE<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 6.1. OVERVIEW<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 6.2. NERVE REPAIR<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 6.2.1. NERVE CONDUITS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 6.2.2. NERVE GRAFTS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;6.2.2.1. ALLOGRAFTS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;6.2.2.2. ACELLULARIZED ALLOGRAFTS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 6.3. NERVE PROTECTION<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 6.3.1. NERVE PROTECTOR<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 6.3.2. NERVE WRAP<\/p>\n<p style=\"text-align: justify;\">7. NERVE REPAIR BIOMATERIALS MARKET, BY INJURY TYPE<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 7.1. OVERVIEW<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 7.2. EPINEURAL NERVE REPAIR<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 7.3. PERINEURAL NERVE REPAIR<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 7.4. GROUP FASCICULAR NERVE REPAIR<\/p>\n<p style=\"text-align: justify;\">&nbsp;8. NERVE REPAIR BIOMATERIALS MARKET, BY END USER<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 8.1. OVERVIEW<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 8.2. HOSPITALS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 8.3. AMBULATORY TRAUMA CENTERS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 8.4. CLINICS<\/p>\n<p style=\"text-align: justify;\">9. NERVE REPAIR BIOMATERIALS MARKET, BY GEOGRAPHY<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 9.1. COUNTRYWISE NERVE REPAIR BIOMATERIALS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; THIS CHAPTER BY COUNTRY)<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 9.1.1. NORTH AMERICA<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.1.1. U.S.<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.1.2. CANADA<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.1.3. MEXICO<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 9.1.2. EUROPE<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.2.1. GERMANY<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.2.2. FRANCE<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.2.3. U.K.<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.2.4. ITALY<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.2.5. SPAIN<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.2.6. RUSSIA<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.2.7. TURKEY<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.2.8. BELGIUM<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.2.9. NETHERLANDS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.2.10. SWITZERLAND<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.2.11. REST OF EUROPE<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 9.1.3. ASIA-PACIFIC (APAC)<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.3.1. JAPAN<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.3.2. CHINA<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.3.3. SOUTH KOREA<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.3.4. INDIA<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.3.5. AUSTRALIA<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.3.6. SINGAPORE<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.3.7. THAILAND<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.3.8. MALAYSIA<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.3.9. INDONESIA<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.3.10. PHILIPPINES<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.3.11. REST OF APAC<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 9.1.4. LATIN AMERICA<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.4.1. BRAZIL<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.4.2. REST OF LATIN AMERICA<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 9.1.5. MIDDLE EAST AND AFRICA<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.5.1. SOUTH AFRICA<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;9.1.5.2. REST OF MIDDLE EAST AND AFRICA<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp;9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES<\/p>\n<p style=\"text-align: justify;\">10. NERVE REPAIR BIOMATERIALS MARKET: COMPETITIVE LANDSCAPE<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;10.1. GLOBAL NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;10.2. U.S. NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;10.3. EUROPE NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;10.4. APAC NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;10.5. SOUTH AMERICA NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;10.6. MIDDLE EAST AND AFRICA&nbsp; NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;10.7. MERGERS &amp; ACQUISITIONS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;10.8. NEW PRODUCT DEVELOPMENT &amp; APPROVALS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;10.9. EXPANSIONS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;10.10. REGULATORY CHANGES<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS<\/p>\n<p style=\"text-align: justify;\">11. NERVE REPAIR BIOMATERIALS MARKET, COMPANY PROFILES<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;11.1. AXOGEN, INC.<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.1.1. COMPANY OVERVIEW<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.1.2. SWOT ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.1.3. REVENUE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.1.4. PRODUCT PORTFOLIO<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.1.5. RECENT DEVELOPEMENTS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.1.6. DATA BRIDGE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;11.2. CHECKPOINT SURGICAL, INC.<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.2.1. COMPANY OVERVIEW<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.2.2. SWOT ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.2.3. REVENUE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.2.4. PRODUCT PORTFOLIO<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.2.5. RECENT DEVELOPEMENTS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.2.6. DATA BRIDGE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;11.3. COLLAGEN MATRIX, INC.<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.3.1. COMPANY OVERVIEW<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.3.2. SWOT ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.3.3. REVENUE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.3.4. PRODUCT PORTFOLIO<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.3.5. RECENT DEVELOPEMENTS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.3.6. DATA BRIDGE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;11.4. INTEGRA LIFESCIENCES CORPORATION<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.4.1. COMPANY OVERVIEW<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.4.2. SWOT ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.4.3. REVENUE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.4.4. PRODUCT PORTFOLIO<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.4.5. RECENT DEVELOPEMENTS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.4.6. DATA BRIDGE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;11.5. POLYGANICS B.V.<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.5.1. COMPANY OVERVIEW<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.5.2. SWOT ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.5.3. REVENUE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.5.4. PRODUCT PORTFOLIO<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.5.5. RECENT DEVELOPEMENTS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.5.6. DATA BRIDGE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp;11.6. STRYKER CORPORATION<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.6.1. COMPANY OVERVIEW<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.6.2. SWOT ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.6.3. REVENUE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.6.4. PRODUCT PORTFOLIO<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.6.5. RECENT DEVELOPEMENTS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.6.6. DATA BRIDGE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; 11.7. SYNOVIS MICRO COMPANIES ALLIANCE, INC.<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.7.1. COMPANY OVERVIEW<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.7.2. SWOT ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.7.3. REVENUE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.7.4. PRODUCT PORTFOLIO<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.7.5. RECENT DEVELOPEMENTS<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.7.6. DATA BRIDGE ANALYSIS<\/p>\n<p style=\"text-align: justify;\">12. APPENDIX<\/p>\n<p style=\"text-align: justify;\">13. ABOUT DATA BRIDGE MARKET RESEARCH<\/p>\n<p style=\"text-align: justify;\"><strong>Browse Related Market Insights:<\/strong><\/p>\n<p style=\"text-align: justify;\">Global Internal Neuromodulation Devices Market, By Product (Spinal Cord Stimulator, Deep Brain Stimulator, Vagus Nerve Stimulator, Sacral Nerve Stimulator, Gastric Nerve Stimulator), By Lead Type (Percutaneous, Paddle Lead), By Indication (Failed Back Surgery Syndrome, Parkinson&rsquo;s disease, Urinary Incontinence, Epilepsy, Gastroparesis), By Battery Type (Primary, Rechargeable), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America, Rest of the World) &ndash; Trends and Forecast to 2024<\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"http:\/\/databridgemarketresearch.com\/reports\/global-internal-neuromodulation-devices-market\/\">Report Insights<\/a><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Data Bridge Market Research Private Limited<br \/><strong>Contact Person:<\/strong> Shubham Dwivedi<br \/><strong>Email:<\/strong> Sales@databridgemarketresearch.com<br \/><strong>Phone:<\/strong> +1-888-387-2818<br \/><strong>Address:<\/strong>Office Number 317, Amanora Chambers, Magarpatta Road, Hadapsar  <br \/><strong>City:<\/strong> Pune<br \/><strong>State:<\/strong> Maharashtra<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a href=\"http:\/\/databridgemarketresearch.com\/reports\/global-nerve-repair-biomaterials-market-trends-forecast-2024\/\" target=\"_blank\" rel=\"nofollow\">http:\/\/databridgemarketresearch.com\/reports\/global-nerve-repair-biomaterials-market-trends-forecast-2024\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/databridgemarketresearch.com\/reports\/global-nerve-repair-biomaterials-market-trends-forecast-2024\/\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=global-nerve-repair-biomaterials-market-industry-analysis-and-forecast-to-2024\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;The actual calculation year for the report in 2016, while the historic data is for 2015 and the forecast period is still 2024&#8221; Global Nerve Repair Biomaterials Market, By Product Type (Nerve Repair (Nerve Conduit, Nerve Graft (Allograft, Acellularized Allograft)), &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/global-nerve-repair-biomaterials-market-industry-analysis-and-forecast-to-2024_123155.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-123155","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/123155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=123155"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/123155\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=123155"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=123155"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=123155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}